Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)

NCT: NCT06784063 · COMPLETED

NCT IDNCT06784063
StatusCOMPLETED
Start Date2025-04-10
Completion2025-06-13
SponsorAlcon Research (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to generate clinical data to quantify the impact of residual astigmatism on the overall visual performance during distance, intermediate, and near viewing in patients implanted with Clareon Vivity IOLs.

Frequently Asked Questions

What is Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)?

Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs) is a clinical trial registered under NCT06784063. Current status: COMPLETED.

What is the status of NCT06784063?

The current status of NCT06784063 (Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)) is: COMPLETED.

When did Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs) start?

Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs) started on 2025-04-10.

Related Devices

K161794CENTURION Vision System (Active SentryTM)Alcon Research, Ltd. K170520HyperVit Vitrectomy Probe, 23 GA, HyperVit Vitrectomy Probe, 25+, HyperVit Vitrectomy Probe, 27+Alcon Research, Ltd. K191650LEGION SystemAlcon Research, LLC PMA P040020Lens, multifocal intraocularAlcon Research, Ltd. PMA P150037Intraocular pressure lowering implantAlcon Research, Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑